0000904454-24-000203.txt : 20240305 0000904454-24-000203.hdr.sgml : 20240305 20240305171908 ACCESSION NUMBER: 0000904454-24-000203 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kapusta Matthew C CENTRAL INDEX KEY: 0001536290 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 24722346 MAIL ADDRESS: STREET 1: 7358 MCVAY ROAD CITY: GERMANTOWN STATE: TN ZIP: 38138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 4 1 edgar.xml PRIMARY DOCUMENT X0508 4 2024-03-01 0 0001590560 uniQure N.V. QURE 0001536290 Kapusta Matthew C C/O UNIQURE, N.V. AMSTERDAM P7 11058BP 1 1 0 0 CEO, Managing Director 0 Ordinary Shares 2024-03-01 4 A 0 150000 0 A 590839 D Stock Option (Right to Buy) 5.59 2024-03-01 4 A 0 259500 0 A 2034-03-01 Ordinary Shares 259500 259500 D Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. /s/ Christian Klemt, Attorney-in-Fact 2024-03-05